Form 8-K - Current report:
SEC Accession No. 0001493152-22-025929
Filing Date
2022-09-15
Accepted
2022-09-15 08:35:37
Documents
14
Period of Report
2022-09-15
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45058
2 ex99-01.htm EX-99.01 12790
3 ex99-01_001.jpg GRAPHIC 2538
  Complete submission text file 0001493152-22-025929.txt   242680

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pali-20220915.xsd EX-101.SCH 3236
5 XBRL LABEL FILE pali-20220915_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE pali-20220915_pre.xml EX-101.PRE 22795
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3762
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 221244543
SIC: 2836 Biological Products, (No Diagnostic Substances)